Comparisons of efficacy and safety of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for treating breast cancer: a retrospective real-world study conducted in China

Comparisons of efficacy and safety of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for treating breast cancer: a retrospective real-world study conducted in China

Bibliographic Details
Main Authors:	J. Wang, Y. Li, Q. Zhu, R. Chen, L. Xu, S. Li, X. Shi, Y. Xu, W. Zhang, X. Huang, X. Zha
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S096097762100165X

Similar Items

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
by: Wu X, et al.
Published: (2021-02-01)

Clinical Research on Albumin-bound Paclitaxel-based Therapy in Advanced Lung Cancer
by: Xu LI, et al.
Published: (2017-06-01)

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
by: Yu Z, et al.
Published: (2020-09-01)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
by: Md Sazzad Hassan, et al.
Published: (2018-04-01)

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study
by: Zhang W, et al.
Published: (2021-03-01)

Efficacy and Safety of Albumin-bound Paclitaxel  in Treating Recurrent Advanced Non-small Cell Lung Cancer
by: Puyuan XING, et al.
Published: (2013-10-01)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01)

Phase II neoadjuvant trial of Albumin-Bound Paclitaxel, Trastuzumab and Pertuzumab followed by anthracycline based regimens in patients with operable Her2 positive breast cancer (OMC-BC05)
by: M. Iwamoto, et al.
Published: (2021-04-01)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
by: Huang L, et al.
Published: (2017-12-01)

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
by: Zhichao Tian, et al.
Published: (2020-07-01)

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
by: Qingmei Li, et al.
Published: (2018-11-01)

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy
by: Cao X, et al.
Published: (2020-03-01)

Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel
by: Margaux Vigata, et al.
Published: (2020-02-01)

Albumin-bound paclitaxel in solid tumors: clinical development and future directions
by: Kundranda MN, et al.
Published: (2015-07-01)

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
by: Francesco Di Costanzo, et al.
Published: (2009-07-01)

Research Progresses of Albumin-bound Paclitaxel in the Treatment of Non-small Cell Lung Cancer
by: Peng LI, et al.
Published: (2010-07-01)

Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.
by: Caitlin Murphy, et al.
Published: (2019-01-01)

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
by: Mashiro Okunaka, et al.
Published: (2020-11-01)

Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (-paclitaxel) in metastatic breast cancer: which benefit for which patients?
by: Raffaella Palumbo, et al.
Published: (2016-05-01)

Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-07-01)

Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography–tandem mass spectrometry
by: Li J, et al.
Published: (2019-05-01)

Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin–Bound Paclitaxel in Rats
by: Yuji Yamashita, et al.
Published: (2011-01-01)

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.
by: Changhua Zhang, et al.
Published: (2013-01-01)

Clinical effect of albumin-bound paclitaxel in treatment of advanced primary liver cancer
by: JI Shiyu, et al.
Published: (2016-10-01)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
by: Zhang MM, et al.
Published: (2016-06-01)

Nanoparticle albumin‐bound paclitaxel in elder patients with advanced squamous non‐small‐cell lung cancer: A retrospective study
by: Yang Liu, et al.
Published: (2020-02-01)

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
by: Shi Y, et al.
Published: (2013-05-01)

Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema
by: Junhyuck Lee, et al.
Published: (2019-01-01)

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
by: Komiya K, et al.
Published: (2016-10-01)

Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen
by: Tang C, et al.
Published: (2018-10-01)

Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis
by: Dou, H., et al.
Published: (2022)

Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Metastatic Breast Cancer: A Meta-Analysis
by: Xin Li, et al.
Published: (2019-10-01)

Albumin-bound formulation of paclitaxel (Abraxane&reg; ABI-007) in the treatment of breast cancer
by: Evelina Miele, et al.
Published: (2009-04-01)

Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel
by: Fransisca Leonard, et al.
Published: (2017-06-01)

Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
by: N. S. Besova, et al.
Published: (2021-06-01)

Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
by: Emad Y. Moawad
Published: (2015-12-01)

Bladder tissue distribution of paclitaxel and docetaxel from polymeric nanoparticles
by: Tsallas, Antonia Theodora
Published: (2010)

Bladder tissue distribution of paclitaxel and docetaxel from polymeric nanoparticles
by: Tsallas, Antonia Theodora
Published: (2010)

Bladder tissue distribution of paclitaxel and docetaxel from polymeric nanoparticles
by: Tsallas, Antonia Theodora
Published: (2010)

Prediction of therapeutic response to paclitaxel, docetaxel and ixabepilone in breast cancer
by: Kadra, Gais
Published: (2011)